Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD)Register to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.0 | 36.5 | -16.5 | 17.6 | 1.3 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 21/11/2024 | USD 1963.40 | |
Day Change | -0.68% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1224415551 | |
Fund Size (Mil) 21/11/2024 | EUR 773.86 | |
Share Class Size (Mil) 21/11/2024 | USD 30.84 | |
Max Initial Charge | - | |
Ongoing Charge 18/10/2024 | 0.96% |
Investment Objective: Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) |
Long-term capital growth by investing in European Equity Markets with a focus on growth stocks of large market capitalization companies in accordance with e/s characteristics. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Giovanni Trombello 12/05/2020 | ||
Andreas Hildebrand 10/10/2023 | ||
Click here to see others | ||
Inception Date 22/05/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P Europe LargeCap Growth NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk AS Class B | Healthcare | 7.93 |
ASML Holding NV | Technology | 7.33 |
DSV AS | Industrials | 6.07 |
SAP SE | Technology | 5.58 |
Sika AG | Basic Materials | 4.38 |
Increase Decrease New since last portfolio | ||
Allianz Global Investors Fund - Allianz Europe Equity Growth Select IT (H2-USD) |